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40-word summary of the article’s main point 
While 14 of 20 Europeans carried multidrug-resistant bacteria at the end of their 3-week visit 
to Laos, whole-genome sequencing of daily stool samples revealed acquisition by all, 
involving multiple transient acquisitions with a potential for longer MDR-GN colonization.  
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Abstract  
 
Background 
Antimicrobial resistance (AMR) is highly prevalent in low- and middle-income countries. 
International travel contributes substantially to the global spread of intestinal multidrug-
resistant gram-negative (MDR-GN) bacteria. Of the 100 million annual visitors to tropical 
countries, 30–70% become colonized by MDR-GN bacteria. The phenomenon has been well 
documented, but since sampling has only been conducted after travelers’ return home, data 
on the actual colonization process are scarce. 
 
Methods 
A group of 20 European volunteers visiting Lao People’s Democratic Republic for three weeks 
provided daily stool samples and filled in daily questionnaires. Acquisition of extended-
spectrum beta-lactamase-producing gram-negative bacteria (ESBL-GN) was examined by 
selective stool cultures followed by whole-genome sequencing (WGS) of isolates.  
 
Results 
While colonization rates were 70% at the end of the study, daily sampling revealed that all 
participants had acquired ESBL-GN at some time point during their overseas stay, the status 
varying day by day. WGS analysis ascribed the transient pattern of colonization to sequential 
acquisition of new strains, resulting in a loss of detectable colonization by the initial MDR-GN 
strains. All but one participant acquired multiple strains (2–5). Of the total of 83 unique strains 
identified (53 E. coli, 10 Klebsiella, 20 other ESBL-GN species), some were shared by as many 
as four subjects. 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/827915doi: bioRxiv preprint first posted online Nov. 7, 2019; 
4 
 
 
Conclusions 
This is the first study to characterize in real time the dynamics of acquiring MDR-GN during 
travel. Our data show multiple transient colonization events indicative of constant microbial 
competition. 
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Introduction 
Antimicrobial resistance (AMR) poses a serious threat to human health worldwide [1]. The 
rapid global spread of multidrug-resistant (MDR) clones of Escherichia coli, Klebsiella 
pneumoniae and other Enterobacteriaceae raises an alarming public health concern [1]. 
Worldwide dissemination of successful clones such as E. coli ST131 has been the primary 
driver in extended-spectrum beta-lactamase (ESBL)-producing E. coli (ESBL-Ec) becoming 
prevalent among clinical isolates [2,3]. Correspondingly, the global spread of carbapenemase-
producing clones of E. coli such as ST410 [4] and ST167 [5], and K. pneumoniae clones such as 
CG258 and ST11 [6,7] largely accounts for the rapid emergence of carbapenem resistance in 
clinical isolates of gram-negative pathogens worldwide.  
 
The literature shows international travel to be strongly associated with acquisition of MDR-
GN strains, mostly ESBL-Ec [8–15]. The carriage rate of intestinal MDR-GN bacteria is highest 
among inhabitants of the Indian subcontinent and Southeast Asia, followed by Africa and 
South America [16]. Not surprisingly, travelers visiting these high-risk regions are at 
substantial risk of acquiring MDR-GN bacteria [15]. Colonization occurs even during short 
visits [8–15] and without antimicrobial use [17] and can last for months or even over a year 
[8,12,13] and lead to further spread after return home [8,13].  Genome-level analysis of MDR 
strains colonizing travelers shows that newly acquired MDR strains tend to displace resident 
intestinal commensal E. coli strains alongside new non-MDR strains, such that the pre-travel 
population remains as a minority [18].  
 
In previous studies of travelers’ intestinal colonization by MDR-GN bacteria, samples have 
been taken immediately prior to travel and upon return to home country [8–14] . As such the 
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dynamics of this competitive colonization process are unknown. Here we present a 
longitudinal study carried out with volunteers visiting the Lao People’s Democratic Republic 
(Laos). Combining daily samples from these travelers during their stay and fine-scale genomic 
analysis enabled us to demonstrate that colonization by MDR-GN bacteria is a highly dynamic 
process. We detected constant switching between the circulating MDR-GN stains acquired by 
individual hosts. Our finding of identical strains colonizing multiple individuals suggests 
common sources of acquisition or transmission between travelers. We also show colonization 
by strains with an alarming prevalence of mcr colistin resistance genes which belong to 
lineages not previously reported as high-risk AMR clones.  
 
Methods 
Study design 
We characterised the colonization process by ESBL-GN through sampling stools on arrival, 
each day abroad, and at departure. The specimens were examined for presumptive ESBL-GN 
by culture, and the isolates were analyzed by whole-genome sequencing. The study protocol 
was approved by the Ethics Committee of the Helsinki University Hospital and the 
Ethikkommission Nordwest- und Zentralschweiz.  All subjects provided written informed 
consent.  
 
Volunteers, samples, and travel destination 
Volunteers were recruited prospectively among participants at a medical course held 19 
September – 9 October, 2015 in Vientiane, Laos. We also invited the recruitees’ companions 
to volunteer. While staying there, each volunteer was asked to provide daily stool samples. 
Those collected within the first two days were considered as baseline samples and the final 
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stools as departure samples. Questionnaires assessing background information and travel-
related data were used at recruitment and before departure. During the stay, the volunteers 
were asked to complete a health card to record gastrointestinal symptoms, food habits, and 
medication use each day. Travelers’ diarrhea (TD) was defined as passage of ≥ 3 loose or liquid 
stools per day. Any ESBL-GN not found in the baseline samples but detected in one or more 
stool samples taken later were defined as travel-acquired ESBL-GN. Only volunteers providing 
at least five daily samples were included in the final subject group (Figure 1).  
 
Stool cultures and phenotypic susceptibility testing  
The initial screening for presumptive ESBL-GN strains from stool samples was conducted in 
Vientiane at the Microbiology Laboratory of Mahosot Hospital by culture on CHROMagarä 
ESBL agar plates (CHROMagar, Paris France). Representative blue and pink colonies were 
subcultured and stored at -80oC in ‘Protect ‘tubes (Technical Service Consultants Ltd, 
Heywood, UK) along with the original swabs. The samples were then transported by plane on 
dry ice first to the Swiss Tropical and Public Health Institute in Basel, and then to the 
University of Helsinki (Finland) for analyses. In Finland, the bacteria were re-cultured on 
ChromID ESBL agar plates (BioMérieux, Marcy-l’Étoile, France) and a representative colony of 
all morphotypes present on the ChromID plate was subcultured and cryopreserved in 
Microbank beads. The isolates were shipped on dry ice to the University of Birmingham for 
genome sequencing by the MicrobesNG facility (http://microbesng.uk). Libraries were 
prepared using the Nextera XT kit, and sequenced on the Illumina HiSeq platform over 250 
cycles.  
Genomic analyses 
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Illumina genome sequence reads were trimmed using Trimmomatic (V 0.3) [19] with a sliding 
window quality of Q15. De novo assembled genomes were produced using SPAdes (V 3.13.0) 
[20]. Resulting assembled genomes were annotated using Prokka (V 1.11) [21]. Antibiotic 
resistance genes were detected in assembled and annotated genomes using Abricate (V 0.8.7, 
https://github.com/tseemann/abricate) and the Resfinder database. Prokka-annotated 
genomes were manually inspected to confirm the presence of resistance genes identified. 
MLST (V 2.15, https://github.com/tseemann/mlst) was used to verify species identification 
and assign classical sequence type designations to isolates. Where isolates were suspected of 
sharing recent source or transmission events, Snippy (V 4.3.6, 
https://github.com/tseemann/snippy) was used to map reads of isolates against the 
assembled genome of the earliest isolated genome. The number of SNPs between strains was 
determined using snp-dists (V 0.6.3, https://github.com/tseemann/snp-dists). Raw sequence 
data for all isolates is available via NCBI under the Bioproject accession number PRJNA558187. 
 
Results 
Description of participants, travel, and symptoms during stay 
A total of 23 volunteers were recruited, three of whom had to be later excluded for having 
only provided two samples (of note, ESBL-GN was found in them all). The final study 
population thus comprised 20 European volunteers (for demographics, see Table 1). Of the 
volunteers, 50% were aged < 50 years, 55% were female, 19 of them MDs participating at a 
medical course. The median age was 42.5 years (IQR 33.5−57.0), and the median duration of 
stay in Laos was 20 (IQR 12−21) days. Five participants (25%) had used antimicrobial 
medication during the previous year, three (15.0%) arrived directly from another tropical 
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region, one (5%) had visited the tropics within the past three months and seven (35%) within 
the last year (Table 1). The group provided a total of 236 stool samples. 
 
Over the sampling period, the volunteers stayed at three separate hotels, lunched and dined 
at various restaurants either in small groups or all together, and participated in daily rounds 
at local hospitals. On the first or second weekend, most volunteers visited the cities of Luang 
Prabang or Vang Vieng. Four of the twenty contracted TD, and one took antibiotics. 
 
All participants were colonized by ESBL-GN, dominated by E. coli 
ESBL-GN strains were detected in the baseline samples of seven of the twenty volunteers, 
including three who had arrived directly from another Asian destination. All volunteers 
provided at least one stool sample positive for ESBL-GN in culture by day 10 of their visit (Fig 
2). Of the 236 fecal samples collected, 174 (73.7%) contained detectable ESBL-GN, yielding a 
total of 306 isolates. E. coli was the most abundant species isolated, accounting for 219 of the 
306 isolates, followed by Citrobacter spp. (28 isolates), Klebsiella spp. (16), Acinetobacter spp. 
(12), Enterobacter cloacae (11), and a number of other low-prevalence species including 
Aeromonas spp. and Stenotrophomonas maltophilia (Table S1). When allocating individual 
isolates to the participants, colonization by any given ESBL-GN during the study period was 
clearly transient in nature, with isolates detected in only one or a few samples obtained from 
any given individual, sometimes with days between isolation.  
 
Genomic analyses of isolates identified competition for colonization both at strain and 
species level 
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The genomes of all 306 isolates were found to contain at least one antimicrobial resistance 
gene. The most prevalent ESBL gene type was blaCTX-M, found in a total of 226 isolates (74%), 
with CTX-M-55 (n=64), CTX-M-14 (n=58), CTX-M-159 (n=57), CTX-M-15 (n=30), and CTX-M-
102 (n=25) as the most common types (Table S2). Some isolates contained multiple CTX-M 
types. Mobile colistin resistance genes (mcr) were found in 82 isolates (28%), all but two of 
which were E. coli (one Aeromonas sp., the other K. pneumoniae). Superimposing MLST 
designation (Figure 2, Figure S1) and bla/mcr gene type (Figure 3) onto each individual 
traveler’s isolates provided further insight into the transient nature of gut colonization. Whilst 
participant 11 was found to have contracted solely an ST2067 E. coli carrying blaCTX-M-15, the 
others were colonized by multiple STs of E. coli and co-colonized by other ESBL-GN species. 
For example, participant 34, who took azithromycin for TD on 21–23 September, was 
transiently colonized by five different E. coli strains over the study period, each with different 
bla gene repertoires. Participant 16 showed a regular flux between isolation of an ST38, ST93, 
and ST101 strain, whilst participant 40 had initial colonization by an ST48 strain later displaced 
by an ST38. All these strains have unique signatures of carriage of multiple bla genes, 
indicating that travelers are exposed to a large number of MDR-GN bacteria and MDR-
conferring genes during the initial colonization process.  
 
Uncommon population structure of ESBL-GN isolates 
We analyzed the population of E. coli isolates at MLST designation level (Figure 4). The most 
common E. coli sequence types identified were ST101, ST34, ST38, and ST195. These lineages 
are very uncommon in surveys of ESBL and carbapenem-resistant E. coli, both in Europe [3] 
and indeed in previous human isolates from Laos [22,23]. Superimposing the presence of 
specific ESBL-Ec and mcr genes onto a phylogenetic tree of the E. coli isolates revealed blaCTX-
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M genes to be ubiquitous throughout the sampled population of isolates, with mcr genes also 
widely distributed across the population (Figure S2). Analysis of the K. pneumoniae lineages 
showed isolates belonging predominantly to ST2176 and ST37, none of which are well 
characterized globally disseminated clones [6,24].  
 
Fine-scale genomic analysis identified common strains infecting participants 
When analyzing the population structure of the E. coli isolates, very little diversity was found 
in strains within each of the different lineages. To investigate relationships between isolates 
within the lineages, we carried out a high-resolution SNP analysis using the first isolated strain 
as a reference. Our data showed a number of common strains colonizing participants, often 
with zero SNPs’ difference between them (Figure 5). An identical ST515 strain colonized 
participants 6, 17, 33, and 5, whilst an identical ST38 colonized participants 5, 40, and 13. 
Participants 19 and 34 shared an identical ST34 strain, whilst participants 6 and 21 shared an 
identical ST385 strain. Participant 11 was colonized on day 8 by an ST2067 also isolated from 
a sample from the travel companion of this participant the following day. With only one 
exception, those belonging to each of these clusters stayed at the same hotel and, according 
to the researchers’ observations, tended to spend a lot of time together.  
 
Discussion 
The impact of travel on the global spread of multidrug-resistant E. coli is well documented. Of 
travelers returning from the Indian subcontinent and Southeast Asia, Africa or South Asia, 20-
80% are colonized by MDR-GN bacteria, most commonly ESBL-Ec [8–15]. This colonization can 
extend over a period of months or even over a year [8,12,13]. Whilst the phenomenon is well 
described, the dynamics of the colonization process and the competition involved have not 
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been thoroughly characterized. Thus far, traveler studies have analyzed pre- and post-travel 
samples [8–14], whereas the actual travel period has not been accurately covered. 
 
Here we monitored 20 European visitors to Laos on a daily basis over a three-week stay. 
Combining their personal data with fine-scale genomic analysis of the strains isolated from 
fecal samples, we demonstrated that establishing colonization by an ESBL-GN strain during 
travel to endemic regions is an extremely dynamic process. We identified a constant influx of 
newly acquired ESBL-GN strains in all but one of the twenty participants. Over the duration 
of their visits, the volunteers were colonized by up to five different strains, and often acquired 
multiple ESBL-GN species. Few traveler studies have employed genome-level analyses [18], 
but several have reported isolating more than one new colonizing ESBL-GN strain from post-
travel samples [10–14]. Our data reveal the true scale and complexity at which drug-resistant 
bacteria colonize the intestinal tract during travel, demonstrating that it has been seriously 
underestimated. In addition, our data clearly show that several of our participants lost some 
of their travel-acquired ESBL-GN strains while still abroad. This indicates that previous studies 
solely employing pre- and post-travel sampling have under-reported the actual extent to 
which travelers are colonized by ESBL-GN. There is a potential caveat to our study in that the 
apparent cyclic disappearance and re-appearance of strains may be related to the sensitivity 
of the culture methods used, and colonizing strains may occasionally have been missed when 
picking colonies for sequencing.   
 
Our fine-scale genomic analysis enabled identification of a number of strains shared by our 
volunteers. Some of the strains colonized up to four participants, often with zero SNPs’ 
difference across the entire genome, and with a maximum of five SNPs’ difference between 
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shared strains. Participants sharing strains stayed at the same hotels and spent time in each 
other’s company. In one exceptional instance, two participants, X and Y (participant 
designations; X an author of this paper) staying in separate accommodations were found to 
share an identical strain (Figure 5).  These two participants had a point of contact, X taking a 
shower in Y’s bathroom.  Whilst direct transmission cannot be confirmed, the clonality of the 
isolates suggests that the two colonization events did not result from exposure to a common 
environmental reservoir. Such reservoirs are generally colonized by bacteria for extended 
periods of time, which leads to extensive diversity within the bacterial population [25,26]. 
Thus, direct transmission or acquisition through common exposure such as consumption of 
food or water appears the most likely explanation.  
 
The population of ESBL-Ec isolates in this study has an unexpected composition. 
Epidemiological surveys of multidrug-resistant E. coli, especially those focusing on ESBL 
strains,  are dominated by E. coli ST131 [27]. Epidemiological investigations carried out on E. 
coli in Laos have also shown ST131 to be the dominant drug-resistant lineage in the country 
[22,23]. However, we isolated no ST131 strains, and ST38 was the only lineage in our study 
that has been reported in studies previously conducted in Laos. They had investigated both 
intestinal colonization isolates [23] and clinical blood stream isolates [22], suggesting that the 
ESBL-Ec population in Laos may be particularly dynamic and prone to frequent fluctuation. 
Interestingly, ST101, ST34, and ST195, and other lineages frequently isolated in our study 
have never been reported as clinical ESBL-Ec isolates in countries such as the United Kingdom 
where high-quality longitudinal data are available [3]. Some reports describe ESBL-Ec ST101 
[28], but none report ST34 or ST195.  E. coli ST38 has been extensively reported as an ESBL-
Ec strain isolated both from humans and animals [29–31].  
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Most previous studies among travelers have only described acquisition of ESBL-E. coli. A few 
have reported multiple findings of ESBL-DEC (diarrheagenic E. coli) [32] or single findings of 
ESBL-Klebsiella [11,14] or carbapenemase-producing E. coli [12,13]. Our data show, in 
addition to ESBL- E. coli (219 of 306 strains, 72%) a substantial number of ESBL-producing non-
E. coli Gram-negative bacteria, such as Citrobacter (9%), Klebsiella (5%), Acinetobacter (4%), 
and Enterobacter cloacae (4%) and even low numbers of Aeromonas spp. and 
Stenotrophomonas maltophilia. This finding may be ascribed to an especially high rate of 
exposure to a variety of MDR-GN bacteria, since 19 of our volunteers attended a course of 
tropical medicine which included daily clinical rounds at local hospitals. High MDR-GN 
colonization rates have been reported among travelers hospitalized in the tropics [33]. 
The complete absence of carbapenemase-producing E. coli in these samples is also 
noteworthy. We screened for ESBL-producing strains, but carbapenemase producers would 
also have grown on the selective plates used. However, WGS analysis showed a complete 
absence of carbapenemase genes, a finding somewhat surprising in Southeast Asia where the 
prevalence of carbapenem-resistant Enterobacteriaceae is increasing [34]. Such isolates have 
only recently been reported in Laos [35], suggesting that carbapenem resistance has not yet 
become a major problem in the country. Even more striking were the extremely high levels 
of the mobile colistin resistance gene mcr in our E. coli isolates. The ST101 lineage which 
dominated our isolate collection has been identified as a driving lineage in the emergence of 
ESBL-Ec, and mcr positive E. coli in the region [36], but we observed the mcr gene across a 
large number of lineages, a finding which may be of substantial importance.  This confirms 
earlier reports showing that travel exacerbates the global spread of not only ESBL genes but 
also E. coli strains carrying mobile colistin resistance genes [37].  
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By combining real-time sampling of travelers with genome-level analyses, we have 
demonstrated that colonization by ESBL-GN during travel is an extremely dynamic process 
characterized by competition between resistant strains and an individual’s own microbiota. 
We have also shown that prevalent strains can colonize multiple travelers via shared routes 
such as transmission or acquisition from a common source. The challenge now lies in 
unraveling the mechanisms that underlie this process and competition between the clones, 
as well as finding tools to prevent colonization already at its initial stages.  
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Table 1. Demographics of participants in our study exploring acquisition of extended-
spectrum beta-lactamase-producing E. coli by daily stool sampling over their visit to Lao 
People’s Democratic Republic in September–October, 2015. 
  
ID Age 
(yrs) 
Sex Country of 
origin 
Arriving from 
(if not country 
of origin) 
Date of arrival  Departure 
date 
Travelers’ 
diarrhoea 
Antibiotic use 
3 33 male Germany  20 Sep 10 Oct 4 Oct  
5 67 male Switzerland  20 Sep 09 Oct   
6 52 male Finland  20 Sep 10 Oct 28 Sep  
8 29 female Switzerland  20 Sep 09 Oct   
9 30 female Austria Vietnam 20 Sep 26 Sept   
11 61 female Finland  20 Sep 10 Oct 25/26 Sep  
12 64 male Austria  10 Sep 09 Oct   
13 38 female Switzerland  20 Sep 10 Oct   
16 62 female Switzerland  19 Sep 17 Oct   
17 53 female Finland USA 21 Sep 10 Oct   
18 46 male Germany  25 Sep 04 Oct   
19 34 female Netherlands  20 Sep 03 Oct   
21 53 female Norway  20 Sep 07 Oct   
23 32 male Austria Vietnam 20 Sep 09 Oct   
26 20 female Switzerland  19 Sep 28 Sep   
33 39 male Germany  13 Sep 24 Oct   
34 35 male Switzerland Thailand 20 Sep 10 Oct 20 Sep–7 Oct 21–23 Sep 
35 63 male Switzerland  19 Sep 28 Sep   
36 52 female Germany  25 Sep 04 Oct   
40 37 female Germany  19 Sep 14 Oct   
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Figure 1. Overview of sampling and analysis workflow with inclusion criteria.  
This study recruited 23 participants who provided daily stool samples. These samples were 
screened for gram-negative extended-spectrum beta-lactamase-producing gram-negative 
(ESBL-GN) bacteria. Participants who produced less than four stool samples (due to 
constipation, for example) were excluded from the final study. Following selective culture, 
isolates were whole-genome sequenced and analysed to determine sequence type, 
resistance profiles, and genomic homology.  
 
Figure 2. Colonization of participants by ESBL-producing gram-negative (ESBL-GN) over a 21-
day period in Lao PDR.  
Patterns of colonization vary dramatically between participants. Some harbored a single 
dominant strain, whilst more transient and frequent strains were detected in the stool 
samples of others. Some participants appeared to have carried a considerably higher load of 
ESBL bacteria (e.g. 21, 34), while others only had one or two samples with ESBL isolates 
(e.g.18, 26). Solid lines represent uninterrupted and concurrent colonization by a single strain. 
Dashed lines represent maintenance of a single strain over multiple days interrupted by 
colonization by another strain of the same species or a period of no growth. Strains are shown 
by participant, with a maximum of five differing strains identified from the samples of a single 
individual. Due to the large number of constituent strains in the database, the color 
designations do not represent the same strains across multiple volunteers. 
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Figure 3.  Resistance determinants identified in ESBL-GN isolates over a 21-day period in Lao 
PDR. 
We detected a highly diverse and abundant set of resistance determinants  with numerous 
CTX-M variants, and a surprising abundance of MCR (28% carriage rate). We also found less 
common ESBL types, such as CMY, VEB, and CFE. Frequent patterns of resistance genes co-
occurred in the same patient, overlapping with instances where a single colonizing strain was 
identified (detailed in Figure 2). Some of these also extended to other participants, (further 
characterized in Figure 5).  Beta-lactamase genes are encoded using symbols, MCR = square, 
CMY = triangle, TEM = diamond, OXA = pentagon, SED = star, ACT = hexagon, VEB = inverted 
triangle, CFE = kite. CTX-M enzymes are encoded in colored circles, with CTX-M subtype 
encoded by different hues. CTX-M-14 = red, 15 = dark orange, 40 = pale orange, 55 = yellow, 
65 = teal, and 102 = navy. 
 
Figure 4. Abundance of unique sequence types amongst the traveler cohort over the 21-day 
study period.  
Isolates were examined using a high-resolution SNP analysis. Strains exhibiting genetic 
heterogeneity were considered unique, and their sequence type was recorded. ST-101 was 
the most abundant sequence type observed. 
 
Figure 5. Linkage of isolates between participants. 
High resolution SNP analysis identified several instances of a single strain colonizing multiple 
participants. These strains differed by ≥5 SNPs, with the most prolifically shared strain (ST-
515) found in participants 06, 17 and 33. Solid lines represent isolates that were identical (i.e. 
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0 SNP’s difference). Dashed lines represent isolates that were found to contain between 1-5 
SNPs. 
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